This company listing is no longer active
LexaGene Holdings Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 0/6
LexaGene Holdings's earnings have been declining at an average annual rate of -14.5%, while the Medical Equipment industry saw earnings declining at 12.8% annually. Revenues have been growing at an average rate of 74.5% per year.
Wichtige Informationen
-14.5%
Wachstumsrate der Gewinne
4.3%
EPS-Wachstumsrate
| Medical Equipment Wachstum der Industrie | -9.5% |
| Wachstumsrate der Einnahmen | 74.5% |
| Eigenkapitalrendite | -670.7% |
| Netto-Marge | -8,189.9% |
| Letzte Ertragsaktualisierung | 30 Nov 2022 |
Jüngste Aktualisierungen vergangener Leistungen
Keine Aktualisierungen
Recent updates
Aufschlüsselung der Einnahmen und Ausgaben
Wie LexaGene Holdings Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 30 Nov 22 | 0 | -9 | 3 | 5 |
| 31 Aug 22 | 0 | -10 | 4 | 5 |
| 31 May 22 | 0 | -10 | 4 | 6 |
| 28 Feb 22 | 0 | -11 | 4 | 6 |
| 30 Nov 21 | 0 | -11 | 5 | 6 |
| 31 Aug 21 | 0 | -11 | 5 | 6 |
| 31 May 21 | 0 | -11 | 5 | 6 |
| 28 Feb 21 | 0 | -10 | 4 | 6 |
| 30 Nov 20 | 0 | -9 | 4 | 5 |
| 31 Aug 20 | 0 | -9 | 3 | 5 |
| 31 May 20 | 0 | -8 | 3 | 5 |
| 29 Feb 20 | 0 | -7 | 3 | 4 |
| 30 Nov 19 | 0 | -8 | 3 | 5 |
| 31 Aug 19 | 0 | -8 | 3 | 5 |
| 31 May 19 | 0 | -8 | 3 | 5 |
| 28 Feb 19 | 0 | -8 | 3 | 5 |
| 30 Nov 18 | 0 | -7 | 3 | 5 |
| 31 Aug 18 | 0 | -7 | 2 | 4 |
| 31 May 18 | 0 | -5 | 2 | 3 |
| 28 Feb 18 | 0 | -4 | 1 | 2 |
| 30 Nov 17 | 0 | -3 | 2 | 2 |
| 31 Aug 17 | 0 | -6 | 1 | 1 |
| 31 May 17 | 0 | -5 | 1 | 1 |
| 28 Feb 17 | 0 | -4 | 1 | 0 |
| 30 Nov 16 | 0 | -4 | 0 | 0 |
| 31 Aug 16 | 0 | 0 | 0 | 0 |
Qualität der Erträge: 0V43 is currently unprofitable.
Wachsende Gewinnspanne: 0V43 is currently unprofitable.
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: 0V43 is unprofitable, and losses have increased over the past 5 years at a rate of 14.5% per year.
Beschleunigtes Wachstum: Unable to compare 0V43's earnings growth over the past year to its 5-year average as it is currently unprofitable
Erträge im Vergleich zur Industrie: 0V43 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-35.4%).
Eigenkapitalrendite
Hohe Eigenkapitalrendite: 0V43 has a negative Return on Equity (-670.69%), as it is currently unprofitable.